InvestorsHub Logo
Followers 56
Posts 5540
Boards Moderated 0
Alias Born 11/04/2011

Re: Amatuer17 post# 104195

Sunday, 05/24/2015 6:12:13 PM

Sunday, May 24, 2015 6:12:13 PM

Post# of 402542
Planning a Phase 2/3 trial before the completion of Phase 1 is a big tell IMO. Leo has been hinting about the efficacy of K as a single agent in the recent PRs. He did the same with B and he was right. So all the "hypes" and "fluffs" about the Phase 2b result turned out to be the truth.

Looking at the current dosage level it seems K will activate P53 and stop new growth of cancer cells but may need supplemental drugs to cancer cells already present - IMO

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News